share_log

HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $25

HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $25

HC Wainwright & Co.维持对Olema Pharmicals的买入,将目标股价下调至25美元
Moomoo 24/7 ·  03/12 06:39

HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $28 to $25.

HC Wainwright & Co. 分析师艾米丽·博德纳尔维持奥莱玛制药公司(纳斯达克股票代码:OLMA)的买入并将目标股价从28美元下调至25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发